- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Managed Care Minute: February 14, 2015
A one-minute look at managed care news during the week of February 9, 2015, including an announcement of a new Affordable Care Initiative and a potential change to recommended dietary guidelines.
HHS announced its new Oncology Care Model, which will promote improving quality of care and reducing costs through better care coordination. The model will focus on 3 key areas: linking payment to quality of care; improving and innovating care delivery; and sharing information more broadly to providers, consumers, and others to support better decision while maintaining privacy.
Plus, the Dietary Guidelines Advisory Committee is prepared to drop cholesterol from its “nutrients of concern” list. Updating the finding on cholesterol reflects a change in thinking about what to recommend for diets for healthy adults, but could affect patients with diabetes.
The committee’s 2015 Dietary Guidelines for Americans will be discussed at Patient-Centered Diabetes Care in Boston on April 16-17. See the full agenda and don’t forget to register.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More
